Treatment Sequence After Initiating Biologic Therapy for Patients With Rheumatoid Arthritis in Korea: A Nationwide Retrospective Cohort Study
Open Access
- 30 August 2022
- journal article
- research article
- Published by Korean College of Rheumatology in Journal of Rheumatic Diseases
- Vol. 30 (1) , 26-35
Abstract
Min Jung Kim, M.D., Jun Won Park, M.D., Sun-Kyung Lee, Ph.D., Yumi Jang, MPH, Soyoung Kim, MPH, Matthias Stoelzel, Ph.D., Jonathan Lumen Chua, Ph.D., Kichul Shin, M.D., Ph.D.. J Rheum Dis -0001;0:. https://doi.org/10.4078/jrd.22.0024Keywords
This publication has 22 references indexed in Scilit:
- 2018 update of the APLAR recommendations for treatment of rheumatoid arthritisInternational Journal of Rheumatic Diseases, 2019
- Diagnosis and Management of Rheumatoid ArthritisJAMA, 2018
- A Clinical Update and Global Economic Burden of Rheumatoid ArthritisEndocrine, Metabolic & Immune Disorders - Drug Targets, 2018
- Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilizationRheumatology International, 2018
- Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritisArthritis Research & Therapy, 2017
- Switching profiles in a population-based cohort of rheumatoid arthritis receiving biologic therapy: results from the KOBIO registryClinical Rheumatology, 2017
- Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA DataJournal of Korean Medical Science, 2017
- Therapeutic Options After Treatment Failure in Rheumatoid Arthritis or SpondyloarthritidesAdvances in Therapy, 2014
- Prevalence and incidence of rheumatoid arthritis in South KoreaRheumatology International, 2012
- Cost of Illness and Quality of Life of Patients with Rheumatoid Arthritis in South KoreaValue in Health, 2012